| Year |
Citation |
Score |
| 2024 |
Walter MN, Montoya-Durango D, Rodriguez W, Wang Y, Zhang J, Chariker JH, Rouchka EC, Maldonado C, Bennett A, McClain CJ, Barve S, Gobejishvili L. Hepatocyte-specific mitogen-activated protein kinase phosphatase 1 in sexual dimorphism and susceptibility to alcohol induced liver injury. Frontiers in Immunology. 15: 1316228. PMID 38370409 DOI: 10.3389/fimmu.2024.1316228 |
0.315 |
|
| 2023 |
Montoya-Durango D, Walter MN, Rodriguez W, Wang Y, Chariker JH, Rouchka EC, Maldonado C, Barve S, McClain CJ, Gobejishvili L. Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies. Biology. 12. PMID 37887031 DOI: 10.3390/biology12101321 |
0.301 |
|
| 2020 |
Li F, Zhao C, Shao T, Liu Y, Gu Z, Jiang M, Li H, Zhang L, Gillevet PM, Puri P, Deng ZB, Chen SY, Barve S, Gobejishvili L, Vatsalya V, et al. Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation. The Journal of Pathology. 252: 371-383. PMID 33245573 DOI: 10.1002/Path.5531 |
0.426 |
|
| 2020 |
Zhao C, Liu L, Liu Q, Li F, Zhang L, Zhu F, Shao T, Barve S, Chen Y, Li X, McClain CJ, Feng W. Corrigendum to 'Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice' Mol Metabol 29 (November 2019) 145-157. Molecular Metabolism. 35: 100999. PMID 32354415 DOI: 10.1016/J.Molmet.2020.100999 |
0.32 |
|
| 2020 |
Wang M, Chen WY, Zhang J, Gobejishvili L, Barve SS, McClain CJ, Joshi-Barve S. Elevated fructose and uric acid via aldose reductase contribute to experimental and human alcoholic liver disease. Hepatology (Baltimore, Md.). PMID 32086945 DOI: 10.1002/hep.31197 |
0.344 |
|
| 2020 |
Elnagdy M, Rodriguez-Alvarez W, Wang Y, Merchant ML, Maldonado C, Barve S, McClain C, Gobejishvili L. Attenuation of fibrogenesis by PDE4 inhibitor via decreased cytoskeleton remodeling, activation and contractility of hepatic stellate cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02928 |
0.354 |
|
| 2020 |
Elnagdy M, Rodriguez W, Wang Y, Merchant M, Bauer P, Maldonado C, Barve S, McClain CJ, Gobejishvili L. Su1692 DECREASED RHO KINASE SIGNALING AND CONTRACTILITY OF HEPATIC STELLATE CELLS BY PDE4 INHIBITOR ATTENUATES FIBROTIC PATHWAYS IN VIVO AND IN VITRO Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)34127-5 |
0.307 |
|
| 2019 |
Rodriguez WE, Wahlang B, Wang Y, Zhang J, Vadhanam MV, Joshi-Barve S, Bauer P, Cannon R, Ahmadi AR, Sun Z, Cameron A, Barve S, Maldonado C, McClain C, Gobejishvili L. PDE4 Inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench. Hepatology (Baltimore, Md.). PMID 31081957 DOI: 10.1002/hep.30761 |
0.373 |
|
| 2019 |
Gobejishvili L, Merchant M, Rodriguez-Alvarez W, Wang Y, Wilkey D, Bauer P, Maldonado C, Barve S, McClain C. Proteomic and Phosphoproteomic Analyses Identify Novel Targets Involved in Beneficial Effect of Rolipram on Liver Fibrosis in Mice The Faseb Journal. 33. DOI: 10.1096/Fasebj.2019.33.1_Supplement.369.12 |
0.337 |
|
| 2018 |
Wahlang B, McClain C, Barve S, Gobejishvili L. Role of cAMP and phosphodiesterase signaling in liver health and disease. Cellular Signalling. PMID 29902522 DOI: 10.1016/J.Cellsig.2018.06.005 |
0.401 |
|
| 2018 |
Shao T, Zhao C, Li F, Gu Z, Liu L, Zhang L, Wang Y, He L, Liu Y, Liu Q, Chen Y, Donde H, Wang R, Jala VR, Barve S, et al. Intestinal HIF-1α Deletion Exacerbates Alcoholic Liver Disease through Inducing Intestinal Dysbiosis and Barrier Dysfunction. Journal of Hepatology. PMID 29803899 DOI: 10.1016/J.Jhep.2018.05.021 |
0.362 |
|
| 2018 |
Moghe A, Barve SS, McClain CJ, Joshi-Barve S. Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV. Cellular and Molecular Gastroenterology and Hepatology. 5: 163-164. PMID 29693044 DOI: 10.1016/J.Jcmgh.2017.11.009 |
0.303 |
|
| 2018 |
Wahlang B, Rodriguez-Alvarez W, Wang Y, Zhang J, Barve S, McClain CJ, Gobejishvili L. Sa1456 - Molecular Mechanisms of PDE4 Inhibition on Alcohol-Induced ER Stress and Hepatocyte Survival in an Alcoholic Liver Injury Model Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33723-5 |
0.405 |
|
| 2018 |
Gobejishvili L, Wahlang B, Rodriguez-Alvarez W, Wang Y, Barve S, McClain CJ. Sa1451 - Role of PDE4 Enzymes in Alcoholic Liver Disease: From Bench to Bedside Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33718-1 |
0.386 |
|
| 2018 |
Vatsalya V, Gobejishvili L, Chen W, Srivastava S, Barve S, McClain CJ, Joshi-Barve S. 989 - Urinary Acrolein Metabolite Levels in Alcoholic Hepatitis Patients – A Pilot Study Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33698-9 |
0.368 |
|
| 2018 |
Wang M, Chen W, Gobejishvili L, Barve S, McClain CJ, Joshi-Barve S. 988 - Aldose Reductase Null Mice are Protected Against Alcohol-Induced Hepatic ER Stress, Apoptosis and Liver Injury Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33697-7 |
0.406 |
|
| 2017 |
Chen WY, Wang M, Zhang J, Barve SS, McClain CJ, Joshi-Barve S. Acrolein disrupts tight junction proteins and causes ER stress-mediated epithelial cell death leading to intestinal barrier dysfunction and permeability. The American Journal of Pathology. PMID 28935573 DOI: 10.1016/J.Ajpath.2017.08.015 |
0.318 |
|
| 2017 |
Avila DV, Myers SA, Zhang J, Kharebava G, McClain CJ, Kim HY, Whittemore SR, Gobejishvili L, Barve S. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology. PMID 28807677 DOI: 10.1016/J.Neuropharm.2017.08.011 |
0.425 |
|
| 2017 |
Donde H, Ghare S, Wilson C, Gail C, Negy L, Gobejishvili L, Joshi-Barve S, McClain C, Barve S. Tributyrin supplementation attenuates alcohol induced dysbiosis and liver injury The Faseb Journal. 31. DOI: 10.1096/Fasebj.31.1_Supplement.994.9 |
0.432 |
|
| 2017 |
Chen W, Zhang J, Wang M, Barve S, McClain C, Joshi-Barve S. Po4-14Acrolein, A By-Product Of Alcohol-Induced Lipid Peroxidation, Impairs Intestinal Epithelial Barrier Function And Causes Gut Permeability Alcohol and Alcoholism. 52. DOI: 10.1093/Alcalc/Agx074.58 |
0.356 |
|
| 2017 |
Ghare S, Joshi-Barve S, McClain C, Barve S. Po4-12Ethanol Inhibits Il-2 Gene Expression In Human Cd4+ T Lymphocytes By Decreasing Promoter Histone H3 Phosphorylation: Relevance To Alcohol Induced Immune Suppression Alcohol and Alcoholism. 52. DOI: 10.1093/Alcalc/Agx074.56 |
0.407 |
|
| 2017 |
Rodriguez-Alvarez W, Zhang J, Perez-Abadia G, McClain CJ, Barve S, Maldonado C, Gobejishvili L. Targeted Delivery of Rolipram to the Liver Using Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)33753-8 |
0.357 |
|
| 2016 |
Chen WY, Zhang J, Ghare S, Barve S, McClain C, Joshi-Barve S. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice. Cellular and Molecular Gastroenterology and Hepatology. 2: 685-700. PMID 28119953 DOI: 10.1016/J.Jcmgh.2016.05.010 |
0.416 |
|
| 2016 |
Vatsalya V, Song M, Schwandt ML, Cave MC, Barve SS, George DT, Ramchandani VA, McClain CJ. Effects of Sex, Drinking History, and Omega-3 and Omega-6 Fatty Acids Dysregulation on the Onset of Liver Injury in Very Heavy Drinking Alcohol-Dependent Patients. Alcoholism, Clinical and Experimental Research. PMID 27589090 DOI: 10.1111/Acer.13197 |
0.408 |
|
| 2016 |
Vatsalya V, Pandey A, Schwandt ML, Cave MC, Barve SS, Ramchandani VA, McClain CJ. Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients. Clinical Drug Investigation. PMID 27503091 DOI: 10.1007/S40261-016-0439-2 |
0.376 |
|
| 2016 |
Vatsalya V, Barve SS, McClain CJ, Ramchandani VA. Elevated Linoleic Acid (A Pro-Inflammatory PUFA) and Liver Injury in a Treatment Naive HIV-HCV Co-Infected Alcohol Dependent Patient. Journal of Biosciences and Medicines. 4: 23-27. PMID 27489857 DOI: 10.4236/Jbm.2016.47003 |
0.384 |
|
| 2016 |
Avila DV, Barker DF, Zhang J, McClain CJ, Barve S, Gobejishvili L. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. The Journal of Pathology. PMID 27287961 DOI: 10.1002/Path.4760 |
0.448 |
|
| 2016 |
Ghare SS, Donde H, Chen WY, Barker DF, Gobejishvilli L, McClain CJ, Barve SS, Joshi-Barve S. Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicology in Vitro : An International Journal Published in Association With Bibra. PMID 27238871 DOI: 10.1016/J.Tiv.2016.05.013 |
0.335 |
|
| 2016 |
Kirpich IA, Petrosino J, Ajami N, Feng W, Wang Y, Liu Y, Beier JI, Barve SS, Yin X, Wei X, Zhang X, McClain CJ. Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease. The American Journal of Pathology. 186: 765-76. PMID 27012191 DOI: 10.1016/J.Ajpath.2015.11.017 |
0.389 |
|
| 2016 |
Gobejishvili L, Vatsalya V, Mohammad MK, Barve S, McClain CJ. Sa1656 Serum TRAIL Levels Inversely Correlate With MELD Scores in Severe Alcoholic Hepatitis Patients Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)33670-8 |
0.361 |
|
| 2015 |
Massey VL, Stocke KS, Schmidt RH, Tan M, Ajami N, Neal RE, Petrosino JF, Barve S, Arteel GE. Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction. Toxicology and Applied Pharmacology. 284: 304-14. PMID 25759243 DOI: 10.1016/J.Taap.2015.02.022 |
0.352 |
|
| 2015 |
Barve S, Kirpich IA, McClain CJ. Tumor necrosis factor alpha-induced receptor 1 signaling in alcoholic liver disease: A gut reaction? Hepatology (Baltimore, Md.). 61: 754-6. PMID 25482079 DOI: 10.1002/Hep.27640 |
0.359 |
|
| 2014 |
Ghare SS, Joshi-Barve S, Moghe A, Patil M, Barker DF, Gobejishvili L, Brock GN, Cave M, McClain CJ, Barve SS. Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 193: 412-21. PMID 24899502 DOI: 10.4049/Jimmunol.1400055 |
0.383 |
|
| 2014 |
Kirpich I, Feng W, Wang Y, Liu Y, Barve S, McClain C. Saturated dietary fat prevented unsaturated fat and alcohol-mediated alterations in gut microbiota resulting in attenuation of intestinal barrier disruption and liver injury in an animal model of alcoholic liver disease (822.9) The Faseb Journal. 28. DOI: 10.1096/Fasebj.28.1_Supplement.822.9 |
0.394 |
|
| 2014 |
Kirpich I, Feng W, Wang Y, Liu Y, Yin X, Barve S, Zhang X, McClain CJ. 386 Dietary Saturated and Unsaturated Fat Differentially Modulate Gut Microbiome, Intestinal Barrier and Liver Injury in a Mouse Model of Alcoholic Liver Disease Gastroenterology. 146: S-911. DOI: 10.1016/S0016-5085(14)63314-X |
0.451 |
|
| 2014 |
Chen W, Zhang J, McClain CJ, Barve S, Joshi-Barve S. 385 Lipid-Derived Aldehyde, Acrolein, Is a Critical Mediator of Alcohol-Induced Gut-Liver Injury Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)63313-8 |
0.416 |
|
| 2013 |
Kirpich I, Zhang J, Gobejishvili L, Kharebava G, Barker D, Ghare S, Joshi-Barve S, McClain CJ, Barve S. Binge ethanol-induced HDAC3 down-regulates Cpt1α expression leading to hepatic steatosis and injury. Alcoholism, Clinical and Experimental Research. 37: 1920-9. PMID 23905631 DOI: 10.1111/Acer.12172 |
0.39 |
|
| 2013 |
Gobejishvili L, Barve S, Breitkopf-Heinlein K, Li Y, Zhang J, Avila DV, Dooley S, McClain CJ. Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4. The Journal of Pharmacology and Experimental Therapeutics. 347: 80-90. PMID 23887098 DOI: 10.1124/Jpet.113.204933 |
0.382 |
|
| 2013 |
Smart L, Gobejishvili L, Crittenden N, Barve S, McClain CJ. Alcoholic Hepatitis: Steroids vs. Pentoxifylline. Current Hepatitis Reports. 12: 59-65. PMID 23750115 DOI: 10.1007/S11901-012-0158-Y |
0.327 |
|
| 2013 |
Kirpich IA, Feng W, Wang Y, Liu Y, Beier JI, Arteel GE, Falkner KC, Barve SS, McClain CJ. Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol. Alcohol (Fayetteville, N.Y.). 47: 257-64. PMID 23453163 DOI: 10.1016/J.Alcohol.2013.01.005 |
0.374 |
|
| 2013 |
Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, Gobejishvili L, Joshi-Barve S, Ayvaz T, Petrosino J, Kong M, Barker D, McClain C, Barve S. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. Plos One. 8: e53028. PMID 23326376 DOI: 10.1371/Journal.Pone.0053028 |
0.425 |
|
| 2013 |
Kharbanda KK, Bardag-Gorce F, Barve S, Molina PE, Osna NA. Impact of altered methylation in cytokine signaling and proteasome function in alcohol and viral-mediated diseases. Alcoholism: Clinical and Experimental Research. 37: 1-7. PMID 22577887 DOI: 10.1111/J.1530-0277.2012.01840.X |
0.412 |
|
| 2013 |
Barve S, Rao R, Chaudhry K, Samak G, Gangwar R, Mir H, Bhargavi M, Isse T, Kawamoto T, Salaspuro M, Kaihovaara P, Kirpich I, Feng W, Wang Y, Liu Y, ... Barve S, et al. S16 * GUT MICROBIOTA, INTESTINAL BARRIER FUNCTION, ENDOTOXEMIA AND ALCOHOLIC LIVER INJURY Alcohol and Alcoholism. 48: i17-i17. DOI: 10.1093/Alcalc/Agt087 |
0.373 |
|
| 2012 |
Mohammad MK, Avila D, Zhang J, Barve S, Arteel G, McClain C, Joshi-Barve S. Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicology and Applied Pharmacology. 265: 73-82. PMID 23026831 DOI: 10.1016/J.Taap.2012.09.021 |
0.335 |
|
| 2012 |
Kirpich I, Ghare S, Zhang J, Gobejishvili L, Kharebava G, Barve SJ, Barker D, Moghe A, McClain CJ, Barve S. Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3. Alcoholism, Clinical and Experimental Research. 36: 1578-86. PMID 22375794 DOI: 10.1111/J.1530-0277.2012.01751.X |
0.36 |
|
| 2012 |
Kirpich IA, Feng W, Wang Y, Liu Y, Barker DF, Barve SS, McClain CJ. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcoholism, Clinical and Experimental Research. 36: 835-46. PMID 22150547 DOI: 10.1111/J.1530-0277.2011.01673.X |
0.409 |
|
| 2011 |
Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, Feng W. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. The American Journal of Pathology. 179: 2866-75. PMID 22093263 DOI: 10.1016/J.Ajpath.2011.08.039 |
0.438 |
|
| 2011 |
Moghe A, Joshi-Barve S, Ghare S, Gobejishvili L, Kirpich I, McClain CJ, Barve S. Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link? World Journal of Gastroenterology. 17: 2465-72. PMID 21633651 DOI: 10.3748/Wjg.V17.I20.2465 |
0.402 |
|
| 2011 |
Ghare S, Patil M, Hote P, Suttles J, McClain C, Barve S, Joshi-Barve S. Ethanol inhibits lipid raft-mediated TCR signaling and IL-2 expression: potential mechanism of alcohol-induced immune suppression. Alcoholism, Clinical and Experimental Research. 35: 1435-44. PMID 21463338 DOI: 10.1111/J.1530-0277.2011.01479.X |
0.393 |
|
| 2011 |
McClain CJ, Barve SS, Barve A, Marsano L. Alcoholic liver disease and malnutrition. Alcoholism, Clinical and Experimental Research. 35: 815-20. PMID 21284673 DOI: 10.1111/J.1530-0277.2010.01405.X |
0.374 |
|
| 2011 |
Gobejishvili L, Avila DV, Barker DF, Ghare S, Henderson D, Brock GN, Kirpich IA, Joshi-Barve S, Mokshagundam SP, McClain CJ, Barve S. S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway. The Journal of Pharmacology and Experimental Therapeutics. 337: 433-43. PMID 21266552 DOI: 10.1124/Jpet.110.174268 |
0.331 |
|
| 2011 |
Kirpich IA, Gobejishvili LN, Bon Homme M, Waigel S, Cave M, Arteel G, Barve SS, McClain CJ, Deaciuc IV. Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry. 22: 38-45. PMID 20303728 DOI: 10.1016/J.Jnutbio.2009.11.009 |
0.367 |
|
| 2010 |
Song M, Chen TS, Barve S, McClain CJ. M1673 Palmitate Induced Interleukin-8 Production From Hepatic Stellate Cells is Toll-Like Receptor 4 Dependent Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)63810-3 |
0.312 |
|
| 2009 |
Joshi-Barve S, Amancherla K, Patil M, Bhatnagar A, Mathews S, Gobejishvili L, Cave M, McClain C, Barve S. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. Free Radical Biology & Medicine. 47: 47-54. PMID 19345260 DOI: 10.1016/J.Freeradbiomed.2009.03.021 |
0.31 |
|
| 2009 |
Jani TS, Gobejishvili L, Hote PT, Barve AS, Joshi-Barve S, Kharebava G, Suttles J, Chen T, McClain CJ, Barve S. Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Research. 19: 358-69. PMID 19048023 DOI: 10.1038/Cr.2008.314 |
0.685 |
|
| 2008 |
Deaciuc IV, Song Z, Peng X, Barve SS, Song M, He Q, Knudsen TB, Singh AV, McClain CJ. Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the disease. Hepatology International. 2: 39-49. PMID 19669278 DOI: 10.1007/S12072-007-9025-2 |
0.349 |
|
| 2008 |
Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (Fayetteville, N.Y.). 42: 675-82. PMID 19038698 DOI: 10.1016/J.Alcohol.2008.08.006 |
0.409 |
|
| 2008 |
Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition. 47: 481-5. PMID 18852641 DOI: 10.1097/Mpg.0B013E31817E2Bfb |
0.348 |
|
| 2008 |
Gobejishvili L, Barve S, Joshi-Barve S, McClain CJ. Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295. PMID 18687753 DOI: 10.1152/Ajpgi.90232.2008 |
0.406 |
|
| 2008 |
Song M, Song Z, Barve S, Zhang J, Chen T, Liu M, Arteel GE, Brewer GJ, McClain CJ. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. The Journal of Pharmacology and Experimental Therapeutics. 325: 409-16. PMID 18299419 DOI: 10.1124/Jpet.107.131227 |
0.349 |
|
| 2008 |
Hote PT, Sahoo R, Jani TS, Ghare SS, Chen T, Joshi-Barve S, McClain CJ, Barve SS. Ethanol inhibits methionine adenosyltransferase II activity and S-adenosylmethionine biosynthesis and enhances caspase-3-dependent cell death in T lymphocytes: relevance to alcohol-induced immunosuppression. The Journal of Nutritional Biochemistry. 19: 384-91. PMID 17869084 DOI: 10.1016/J.Jnutbio.2007.05.010 |
0.696 |
|
| 2008 |
Chang W, McClain CJ, Liu MC, Barve SS, Chen TS. Effects of 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid on 4-hydroxy-2-nonenal-induced apoptotic T cell death. The Journal of Nutritional Biochemistry. 19: 184-92. PMID 17618106 DOI: 10.1016/J.Jnutbio.2007.02.008 |
0.411 |
|
| 2008 |
Gobejishvili L, Khan R, Joshi-Barve S, Barve S, McClain CJ, Hill DB. S1927 Misoprostol, a Potential Therapeutic Agent for Alcoholic Hepatitis, Modulates Cytokine Activity Through cAMP Pathway Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)63669-0 |
0.404 |
|
| 2007 |
Donohue TM, Cederbaum AI, French SW, Barve S, Gao B, Osna NA. Role of the proteasome in ethanol-induced liver pathology Alcoholism: Clinical and Experimental Research. 31: 1446-1459. PMID 17760783 DOI: 10.1111/J.1530-0277.2007.00454.X |
0.406 |
|
| 2007 |
Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology (Baltimore, Md.). 46: 823-30. PMID 17680645 DOI: 10.1002/Hep.21752 |
0.388 |
|
| 2007 |
Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz N, Kharbanda KK, Liu QY, Lu SC, McClain CJ, Swanson C, Zakhari S. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. The American Journal of Clinical Nutrition. 86: 14-24. PMID 17616758 DOI: 10.1093/Ajcn/86.1.14 |
0.446 |
|
| 2007 |
Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. The Journal of Nutritional Biochemistry. 18: 184-95. PMID 17296492 DOI: 10.1016/J.Jnutbio.2006.12.006 |
0.346 |
|
| 2006 |
Barve S, Joshi-Barve S, Song Z, Hill D, Hote P, Deaciuc I, McClain C. Interactions of cytokines, S-Adenosylmethionine, and S-Adenosylhomocysteine in alcohol-induced liver disease and immune suppression. Journal of Gastroenterology and Hepatology. 21: S38-42. PMID 16958670 DOI: 10.1111/J.1440-1746.2006.04590.X |
0.45 |
|
| 2006 |
Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. American Journal of Physiology. Gastrointestinal and Liver Physiology. 291: G681-8. PMID 16751174 DOI: 10.1152/Ajpgi.00098.2006 |
0.404 |
|
| 2006 |
Brozovic S, Sahoo R, Barve S, Shiba H, Uriarte S, Blumberg RS, Kinane DF. Porphyromonas gingivalis enhance FasL expression via up-regulations if NFκB-mediated gene transcription and induces apoptopic cell death in human gingival epithelial cells Microbiology. 152: 797-806. PMID 16514159 DOI: 10.1099/Mic.0.28472-0 |
0.371 |
|
| 2005 |
McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, Hill D. Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcoholism, Clinical and Experimental Research. 29: 180S-8S. PMID 16344606 DOI: 10.1097/01.Alc.0000189276.34230.F5 |
0.43 |
|
| 2005 |
Uriarte SM, Joshi-Barve S, Song Z, Sahoo R, Gobejishvili L, Jala VR, Haribabu B, McClain C, Barve S. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes. Cell Death and Differentiation. 12: 233-42. PMID 15665818 DOI: 10.1038/Sj.Cdd.4401549 |
0.396 |
|
| 2005 |
Goldstein JW, Chen T, Khan R, Lanter J, Barve S, McClain C, Hill DB. Increased S-Adenosylhomocysteine (SAH) May Predispose to TNF Liver Injury in Human Alcoholic Liver Disease (ALD): 364 The American Journal of Gastroenterology. 100. DOI: 10.14309/00000434-200509001-00364 |
0.403 |
|
| 2005 |
Chang WY, Sahoo R, Srivastava S, McClain CJ, Chen TS, Barve SS. Mechanisms Of 4-Hydroxynonenal-hne (Lipid Hydroperoxide) Induced Apoptotic Death In Cd4 T Lymphocytes: Relevance To Hiv And Hcv Pathogenesis Therapeutic Drug Monitoring. 27: 246. DOI: 10.1097/00007691-200504000-00152 |
0.324 |
|
| 2005 |
Modi TD, Uriarte S, Sahoo R, Barve SJ, McClain C, Barve S. Methionine Adenosyltransferase IIA (MAT IIA) Activity And S-adenosylmethionine (Same) Biosynthesis Play A Critical Role In The Survival Of CD4+ T Cells By Regulating Akt Activation And FasL-mediated Activation Induced Cell Death (AICD): 97 Therapeutic Drug Monitoring. 27: 235. DOI: 10.1097/00007691-200504000-00112 |
0.396 |
|
| 2004 |
McClain CJ, Mokshagundam SPL, Barve SS, Song Z, Hill DB, Chen T, Deaciuc I. Mechanisms of non-alcoholic steatohepatitis Alcohol. 34: 67-79. PMID 15670668 DOI: 10.1016/J.Alcohol.2004.07.007 |
0.377 |
|
| 2004 |
Song Z, Chen T, Deaciuc IV, Uriarte S, Hill D, Barve S, McClain CJ. Modulation of endotoxin stimulated interleukin-6 production in monocytes and Kupffer cells by S-adenosylmethionine (SAMe). Cytokine. 28: 214-23. PMID 15566950 DOI: 10.1016/J.Cyto.2004.08.004 |
0.31 |
|
| 2004 |
Song Z, Zhou Z, Uriarte S, Wang L, Kang YJ, Chen T, Barve S, McClain CJ. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology (Baltimore, Md.). 40: 989-97. PMID 15382170 DOI: 10.1002/Hep.20412 |
0.478 |
|
| 2004 |
McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease American Journal of Physiology - Gastrointestinal and Liver Physiology. 287. PMID 15331349 DOI: 10.1152/Ajpgi.00171.2004 |
0.433 |
|
| 2003 |
Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology (Baltimore, Md.). 38: 1178-87. PMID 14578856 DOI: 10.1053/Jhep.2003.50470 |
0.403 |
|
| 2003 |
Song Z, Zhou Z, Chen T, Hill D, Kang J, Barve S, McClain C. S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice. The Journal of Nutritional Biochemistry. 14: 591-7. PMID 14559110 DOI: 10.1016/S0955-2863(03)00116-5 |
0.436 |
|
| 2003 |
Song Z, Barve S, Chen T, Nelson W, Uriarte S, Hill D, McClain C. S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes. American Journal of Physiology. Gastrointestinal and Liver Physiology. 284: G949-55. PMID 12736147 DOI: 10.1152/Ajpgi.00426.2002 |
0.335 |
|
| 2003 |
Mendez C, Hill D, Marsano L, Valentino K, Barve S, McClain C. Interleukin-18 metabolism in alcoholic and non-alcoholic steatohepatitis Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83640-5 |
0.355 |
|
| 2002 |
McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, Barve S. S-Adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol (Fayetteville, N.Y.). 27: 185-92. PMID 12163148 DOI: 10.1016/S0741-8329(02)00224-0 |
0.403 |
|
| 2002 |
Barve SS, Kelkar SV, Gobejishvilli L, Joshi-Barve S, McClain CJ. Mechanisms of alcohol-mediated CD4+ T lymphocyte death: relevance to HIV and HCV pathogenesis. Frontiers in Bioscience : a Journal and Virtual Library. 7: d1689-96. PMID 12086912 DOI: 10.2741/Barve |
0.437 |
|
| 2002 |
McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. Monocyte activation in alcoholic liver disease Alcohol. 27: 53-61. PMID 12062638 DOI: 10.1016/S0741-8329(02)00212-4 |
0.388 |
|
| 2002 |
Kelkar S, Dong Q, Xiao Y, Joshi-Barve S, McClain CJ, Barve SS. Ethanol enhances activation-induced caspase-3 dependent cell death in T lymphocytes. Alcoholism, Clinical and Experimental Research. 26: 363-70. PMID 11923590 DOI: 10.1111/J.1530-0277.2002.Tb02547.X |
0.45 |
|
| 2001 |
Barve S, Joshi-Barve S. Protessonme inhibition increases hepatocyte IL-8 and IL-18: Implications for alcoholic liver disease Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81811-2 |
0.348 |
|
| 2001 |
Barve S, Das S, Joshi-Barve S, Chawla R, Hill DB, McClain CJ. S-adenosyl-1 methionine (SAMe) protects sensitized hepatocytes from TNF induced caspase activation and apoptotic death* Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)81796-9 |
0.345 |
|
| 2001 |
Yang F, Oz H, Barve S, Devilliers WJ, McClain CJ, Varilek G. The green tea polyphenol, (−)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting ikappaB kinase activity in the intestinal epithelial cell line, IEC-6 Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)80931-6 |
0.312 |
|
| 1999 |
McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Seminars in Liver Disease. 19: 205-219. PMID 10422201 DOI: 10.1055/S-2007-1007110 |
0.456 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Gu Z, Li F, Liu Y, Jiang M, Zhang L, He L, Wilkey DW, Merchant M, Zhang X, Deng ZB, Chen SY, Barve S, McClain CJ, Feng W. Exosome-Like Nanoparticles From GG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice. Hepatology Communications. 5: 846-864. PMID 34027273 DOI: 10.1002/hep4.1679 |
0.298 |
|
| 2012 |
Gobejishvili L, Breitkopf-Heinlein K, Zhang J, Avila D, Dooley S, Barve S, McClain CJ. 386 Development of Liver Inflammation and Fibrosis is Critically Regulated by Phosphodiesterase 4 Sub-Family Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)63548-3 |
0.298 |
|
| 2006 |
Girvan AC, Teng Y, Casson LK, Thomas SD, Jüliger S, Ball MW, Klein JB, Pierce WM, Barve SS, Bates PJ. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Molecular Cancer Therapeutics. 5: 1790-9. PMID 16891465 DOI: 10.1158/1535-7163.Mct-05-0361 |
0.297 |
|
| 2021 |
Singhal R, Donde H, Ghare S, Stocke K, Zhang J, Vadhanam M, Reddy S, Gobejishvili L, Chilton P, Joshi-Barve S, Feng W, McClain C, Hoffman K, Petrosino J, Vital M, ... Barve S, et al. Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice. Gut Microbes. 13: 1946367. PMID 34369304 DOI: 10.1080/19490976.2021.1946367 |
0.296 |
|
| 2009 |
Gobejishvili L, Barve S, Barve AJ, Joshi-Barve S, Song Z, McClain CJ. S1593 S-Adenosylmethionine (SAM) Down-Regulates LPS-Inducible Phosphodiesterase 4 Activity, Increases cAMP Levels and Decreases TNFα Expression in Monocytes: Relevance to Alcoholic Liver Disease Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)63783-5 |
0.293 |
|
| 2017 |
Barve S, Chen SY, Kirpich I, Watson WH, Mcclain C. Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition. Alcohol Research : Current Reviews. 38: 289-302. PMID 28988580 |
0.293 |
|
| 2000 |
Barve S, Joshi-Barve S, Das S, Schmidt J, Hill D, McClain CJ. Inhibition of proteasome function induces IL-8 expression in human hepatoma cell line, Hep G2 Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85815-1 |
0.287 |
|
| 2001 |
Donohue TM, Clemens DL, Galli A, Crabb D, Nieto N, Kato J, Barve SS. Use of Cultured Cells in Assessing Ethanol Toxicity and Ethanol-Related Metabolism Alcoholism: Clinical and Experimental Research. 25. DOI: 10.1111/J.1530-0277.2001.Tb02380.X |
0.286 |
|
| 1995 |
Barve S, Joshi-Barve S, Talwalker R, McClain CJ, Varilek GW. Mesalamine (5-ASA) and the anti-oxidant, vitamin E inhibit interleukin-1 (IL-1) mediated activation of nuclera factor-κB (NFκB) in CACO-2 cells Gastroenterology. 108. DOI: 10.1016/0016-5085(95)27419-7 |
0.283 |
|
| 2015 |
Barve S, Kapoor R, Moghe A, Ramirez JA, Eaton JW, Gobejishvili L, Joshi-Barve S, McClain CJ. Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients. Alcohol Research & Health : the Journal of the National Institute On Alcohol Abuse and Alcoholism. 33: 229-36. PMID 23584064 |
0.277 |
|
| 2023 |
Ghare SS, Charpentier BT, Ghooray DT, Zhang J, Vadhanam MV, Reddy S, Joshi-Barve S, McClain CJ, Barve SS. Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury. Nutrients. 15. PMID 37892472 DOI: 10.3390/nu15204397 |
0.277 |
|
| 2005 |
Song Z, Uriarte S, Sahoo R, Chen T, Barve S, Hill D, McClain C. S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor. Biochimica Et Biophysica Acta. 1743: 205-13. PMID 15843034 DOI: 10.1016/J.Bbamcr.2004.12.001 |
0.276 |
|
| 2012 |
Kirpich I, Feng W, Wang Y, Liu Y, Barve S, McClain CJ. 825 The Role of Ethanol and Unsaturated Fat Diet Mediated Intestinal Inflammation in the Disruption of Intestinal Barrier Integrity in an Animal Model of Alcoholic Liver Disease Gastroenterology. 142: S-929. DOI: 10.1016/S0016-5085(12)63605-1 |
0.271 |
|
| 2001 |
McClain CJ, Chawla R, Nelson W, Watson W, Skufca D, Doss S, Hill DB, Barve S. S-adenosylmethionine (SAMe) modulates IL-10 and TNF production by monocytes, macophages, and kupffer cells Gastroenterology. 120. DOI: 10.1016/S0016-5085(08)80319-8 |
0.27 |
|
| 2005 |
Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. The Journal of Pediatrics. 147: 835-838. PMID 16356442 DOI: 10.1016/J.Jpeds.2005.07.030 |
0.27 |
|
| 2015 |
Moghe A, Ghare S, Lamoreau B, Mohammad M, Barve S, McClain C, Joshi-Barve S. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicological Sciences : An Official Journal of the Society of Toxicology. 143: 242-55. PMID 25628402 DOI: 10.1093/Toxsci/Kfu233 |
0.269 |
|
| 2023 |
Elnagdy M, Wang Y, Rodriguez W, Zhang J, Bauer P, Wilkey DW, Merchant M, Pan J, Farooqui Z, Cannon R, Rai S, Maldonado C, Barve S, McClain CJ, Gobejishvili L. Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration. The Journal of Pathology. PMID 37735782 DOI: 10.1002/path.6194 |
0.268 |
|
| 2019 |
Zhao C, Liu L, Liu Q, Li F, Zhang L, Zhu F, Shao T, Barve S, Chen Y, Li X, McClain CJ, Feng W. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Molecular Metabolism. 29: 145-157. PMID 31668386 DOI: 10.1016/j.molmet.2019.08.020 |
0.264 |
|
| 2016 |
Chen W, Zhang J, Barve S, McClain CJ, Joshi-Barve S. Su1192 Acrolein, a Lipid-Derived Endogenous Aldehyde and Environmental/Dietary Pollutant, Disrupts Barrier Integrity in Intestinal Epithelial Cells Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)31691-2 |
0.26 |
|
| 2012 |
Mohammad MK, Lamoreau B, Mathews S, Barve S, McClain CJ, Joshi-Barve S. Su1605 Lipid Peroxidation Product and Environmental Pollutant, Acrolein, Impedes IFNα anti-HCV Activity via Stat Alterations and Promoter-Associated Epigenetic Modifications Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)63784-6 |
0.258 |
|
| 2018 |
Vatsalya V, Kong M, Gobejishvili L, Chen WY, Srivastava S, Barve S, McClain CJ, Joshi-Barve S. Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 30234998 DOI: 10.1152/Ajpgi.00209.2018 |
0.254 |
|
| 2020 |
Elnagdy M, Barve S, McClain C, Gobejishvili L. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules. 10. PMID 33050657 DOI: 10.3390/biom10101433 |
0.244 |
|
| 2004 |
Marsano LS, Mendez C, Hill D, Barve S, McClain CJ. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Research & Health : the Journal of the National Institute On Alcohol Abuse and Alcoholism. 27: 247-56. PMID 15535453 |
0.242 |
|
| 2020 |
Ghare SS, Chilton PM, Rao AV, Joshi-Barve S, Peyrani P, Vega AR, McClain CJ, Bryant K, Cook RL, Freiberg M, Barve S. Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33093334 DOI: 10.1097/QAI.0000000000002526 |
0.235 |
|
| 2019 |
Donde H, Ghare S, Joshi-Barve S, Zhang J, Vadhanam MV, Gobejishvili L, Lorkiewicz P, Srivastava S, McClain CJ, Barve S. Tributyrin inhibits ethanol-induced epigenetic repression of CPT-1A and attenuates hepatic steatosis and injury. Cellular and Molecular Gastroenterology and Hepatology. PMID 31654770 DOI: 10.1016/J.Jcmgh.2019.10.005 |
0.235 |
|
| 2019 |
Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, Jiang M, Zhou Y, Barve S, Zhang X, McClain CJ, et al. Probiotic LGG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology (Baltimore, Md.). PMID 31571251 DOI: 10.1002/Hep.30975 |
0.234 |
|
| 2014 |
Fernandez-Botran R, Joshi-Barve S, Ghare S, Barve S, Young M, Plankey M, Bordon J. Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infections. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 885-93. PMID 24955730 DOI: 10.1089/Jir.2014.0006 |
0.232 |
|
| 2017 |
Chen W, Zhang J, Wang M, Barve S, McClain CJ, Joshi-Barve S. Intestinal Epithelial Barrier Function is Disrupted by Acrolein, an Environmental/Dietary Pollutant and Lipid Metabolite Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)32032-2 |
0.231 |
|
| 2018 |
Jones DZ, Schmidt ML, Suman S, Hobbing KR, Barve SS, Gobejishvili L, Brock G, Klinge CM, Rai SN, Park J, Clark GJ, Agarwal R, Kidd LR. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. Bmc Cancer. 18: 421. PMID 29653561 DOI: 10.1186/S12885-018-4258-0 |
0.229 |
|
| 2013 |
Jones D, Anene D, Aloway A, Anene P, Avila D, Gobejishvili L, Barve S, McNally L, Kidd L. Abstract 1844: Reduced expression of miR-342-3p in prostate cancer. Cancer Research. 73: 1844-1844. DOI: 10.1158/1538-7445.Am2013-1844 |
0.226 |
|
| 2017 |
Suman S, Jones-Reed DZ, Schmidt ML, Clark GJ, Klinge C, Barve S, Kimbro KS, Kidd LCR. Abstract 1483: Alteration of miR-186 expression modifies inflammatory markers in normal epithelial and prostate cancer cell models Cancer Research. 77: 1483-1483. DOI: 10.1158/1538-7445.Am2017-1483 |
0.222 |
|
| 2002 |
McClain CJ, McClain M, Barve S, Boosalis MG. Trace metals and the elderly Clinics in Geriatric Medicine. 18: 801-818. PMID 12608504 DOI: 10.1016/S0749-0690(02)00040-X |
0.215 |
|
| 2001 |
Wadhwa P, Culhane J, Chicz-Demet A, Barve S, Rauh V, Farley-McCollum K, Hogan V. 550 Maternal stress, endocrine/immune-inflammatory processes and vaginal infection in human pregnancy: Preliminary findings American Journal of Obstetrics and Gynecology. 185: S230. DOI: 10.1016/S0002-9378(01)80583-4 |
0.213 |
|
| 2012 |
Kidd LR, Jones DZ, Rogers EN, Kidd NC, Beache S, Rudd JE, Ragin C, Jackson M, McFarlane-Anderson N, Tulloch-Reid M, Morrison S, Brock GN, Barve SS, Kimbro KS. Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. Hereditary Cancer in Clinical Practice. 10: 16. PMID 23168091 DOI: 10.1186/1897-4287-10-16 |
0.212 |
|
| 2009 |
Buell J, Joshi-Barve S, Gobin A, Gobejishvili L, Zhang J, Li Y, McClain CJ, Barve S. W1776 Development and Evaluation of Gold Nanoparticle Based Laser Nano Thermolysis As a Potential New Active Intervention: A Novel Therapeutic Approach to Hepatocellular Cancer Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)63962-7 |
0.204 |
|
| 2001 |
Wadhwa PD, Culhane JF, Rauh V, Barve SS. Stress and Preterm Birth: Neuroendocrine, Immune/Inflammatory, and Vascular Mechanisms Maternal and Child Health Journal. 5: 119-125. PMID 11573837 DOI: 10.1023/A:1011353216619 |
0.204 |
|
| 2007 |
McClain CJ, Barve S, Deaciuc I. Good fat/bad fat. Hepatology. 45: 1343-1346. PMID 17538963 DOI: 10.1002/Hep.21788 |
0.195 |
|
| 2019 |
Liu Q, Liu Y, Li F, Gu Z, Liu M, Shao T, Zhang L, Zhou G, Pan C, He L, Cai J, Zhang X, Barve S, McClain CJ, Chen Y, et al. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. The Journal of Nutritional Biochemistry. 75: 108256. PMID 31760308 DOI: 10.1016/J.Jnutbio.2019.108256 |
0.194 |
|
| 1998 |
Devalarja R, Barve S, Hill D, McClain C. Acetaminophen hepatotoxicity: new insights Gastroenterology. 114. DOI: 10.1016/S0016-5085(98)85005-1 |
0.191 |
|
| 2022 |
Jiang M, Li F, Liu Y, Gu Z, Zhang L, Lee J, He L, Vatsalya V, Zhang HG, Deng Z, Zhang X, Chen SY, Guo GL, Barve S, McClain CJ, et al. Probiotic-derived Nanoparticles Inhibit ALD through Intestinal miR194 Suppression and Subsequent FXR Activation. Hepatology (Baltimore, Md.). PMID 35689610 DOI: 10.1002/hep.32608 |
0.19 |
|
| 2020 |
Anders L, Vadhanam M, Elmasry M, Gobejishvlli L, Rejc E, Stocker A, Barve S, Abell T. Su1717 CHEMOKINE ELEVATION IN PATIENTS WITH THE SYMPTOMS OF GASTROPARESIS Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)32245-9 |
0.183 |
|
| 2004 |
McClain CJ, Hill DB, Barve SS. Infliximab and prednisolone: Too much of a good thing? Hepatology. 39: 1488-1490. PMID 15185287 DOI: 10.1002/Hep.20267 |
0.178 |
|
| 2022 |
Gobejishvili L, Rodriguez WE, Bauer P, Wang Y, Soni C, Lydic T, Barve S, McClain C, Maldonado C. Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis. Drug Design, Development and Therapy. 16: 1301-1309. PMID 35535222 DOI: 10.2147/DDDT.S355796 |
0.178 |
|
| 2018 |
Vatsalya V, Cave M, Kumar R, Srivastava S, Khanal S, Jenson A, Schwandt M, Barve SS, Ramchandani V, McClain C. Alterations in serum zinc and polyunsaturated fatty acid concentrations in treatment naïve HIV-diagnosed alcohol dependent subjects with liver injury. Aids Research and Human Retroviruses. PMID 30280905 DOI: 10.1089/Aid.2018.0124 |
0.173 |
|
| 2021 |
Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, ... ... Barve SS, et al. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. Jci Insight. 6. PMID 33986193 DOI: 10.1172/jci.insight.148435 |
0.163 |
|
| 2016 |
Vatsalya V, Avila D, Frimodig JC, Barve SS, McClain CJ, Gobejishvili L. Liver Injury Assessment by Vetscan VS2 Analyzer and Most Frequently Used ALT/GTP Reagent. Gastroenterology & Hepatology (Bartlesville, Okla.). 4. PMID 27275009 DOI: 10.15406/ghoa.2016.04.00107 |
0.163 |
|
| 2017 |
McClain C, Barve S. A Tale of Two Institutions. Journal of Hepatology. PMID 28137431 DOI: 10.1016/J.Jhep.2017.01.016 |
0.161 |
|
| 2018 |
Myers SA, Gobejishvili L, Saraswat Ohri S, Garrett Wilson C, Andres KR, Riegler AS, Donde H, Joshi-Barve S, Barve S, Whittemore SR. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiology of Disease. 124: 353-363. PMID 30557659 DOI: 10.1016/j.nbd.2018.12.008 |
0.149 |
|
| 2004 |
Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. Journal of the American College of Nutrition. 23: 71-8. PMID 14963056 DOI: 10.1080/07315724.2004.10719345 |
0.133 |
|
| 2024 |
Cook RL, Richards VL, Gullett JM, Lerner BDG, Zhou Z, Porges EC, Wang Y, Kahler CW, Barnett NP, Li Z, Pallikkuth S, Thomas E, Rodriguez A, Bryant KJ, Ghare S, ... Barve S, et al. Experimentally Induced Reductions in Alcohol Consumption and Brain, Cognitive, and Clinical Outcomes in Older Persons With and Those Without HIV Infection (30-Day Challenge Study): Protocol for a Nonrandomized Clinical Trial. Jmir Research Protocols. 13: e53684. PMID 38564243 DOI: 10.2196/53684 |
0.127 |
|
| 2022 |
Ghare S, Singhal R, Bryant V, Gautam S, Tirumala CC, Srisailam PK, Reyes-Vega A, Ghooray D, McClain CJ, Hoffman K, Petrosino J, Bryant K, Govind V, Cohen R, Cook RL, ... Barve S, et al. Age-Associated Gut Dysbiosis, Marked by Loss of Butyrogenic Potential, Correlates With Altered Plasma Tryptophan Metabolites in Older People Living With HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 89: S56-S64. PMID 35015746 DOI: 10.1097/QAI.0000000000002866 |
0.107 |
|
| 2020 |
Hong KU, Doll MA, Lykoudi A, Salazar-González RA, Habil MR, Walls KM, Bakr AF, Ghare SS, Barve SS, Arteel GE, Hein DW. Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for -Acetyltransferase 2. Toxicology Reports. 7: 1319-1330. PMID 33083237 DOI: 10.1016/j.toxrep.2020.09.011 |
0.102 |
|
| 2021 |
Chichetto NE, Kundu S, Freiberg MS, Koethe JR, Butt AA, Crystal S, So-Armah KA, Cook RL, Braithwaite RS, Justice AC, Fiellin DA, Khan M, Bryant KJ, Gaither JR, Barve SS, et al. Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection. Aids and Behavior. PMID 34101074 DOI: 10.1007/s10461-021-03327-4 |
0.101 |
|
| 2019 |
Chichetto NE, Kundu S, Freiberg MS, Butt AA, Crystal S, So-Armah KA, Cook RL, Braithwaite RS, Fiellin DA, Khan MR, Bryant KJ, Gaither JR, Barve SS, Crothers K, Bedimo RJ, et al. Association of Syndemic Unhealthy Alcohol Use, Cigarette Use, and Depression With All-Cause Mortality Among Adults Living With and Without HIV Infection: Veterans Aging Cohort Study. Open Forum Infectious Diseases. 6: ofz188. PMID 31211153 DOI: 10.1093/Ofid/Ofz188 |
0.097 |
|
| 2023 |
Knibbe CA, Ahmed RU, Wilkins F, Sharma M, Ethridge J, Morgan M, Gibson D, Cooper KB, Howland DR, Vadhanam MV, Barve SS, Davison S, Sherwood LC, Semler J, Abell T, et al. SmartPill™ Administration to Assess Gastrointestinal Function after Spinal Cord Injury in a Porcine Model-A Preliminary Study. Biomedicines. 11. PMID 37371755 DOI: 10.3390/biomedicines11061660 |
0.086 |
|
| 2024 |
Harris LM, Kerr JC, Skidmore BD, Ghare S, Reyes-Vega A, Remenik-Zarauz V, Samanapally H, Anwar RU, Rijal R, Bryant K, Hall MT, Barve S. A conceptual analysis of SBIRT implementation alongside the continuum of PrEP awareness: domains of fit and feasibility. Frontiers in Public Health. 11: 1310388. PMID 38259734 DOI: 10.3389/fpubh.2023.1310388 |
0.059 |
|
| 2023 |
Ghare S, Gardener H, Ariko T, Gutierrez J, Wright CB, Goldberg RB, Elkind MSV, Cooper GE, Shields CB, Barve S, Rundek T. Osteopontin is associated with dementia in the presence of cerebral small vessel disease. Cerebrovascular Diseases (Basel, Switzerland). PMID 37673055 DOI: 10.1159/000533953 |
0.058 |
|
| 2021 |
Hamorsky KT, Bushau-Sprinkle AM, Kitterman K, Corman JM, DeMarco J, Keith RJ, Bhatnagar A, Fuqua JL, Lasnik A, Joh J, Chung D, Klein J, Flynn J, Gardner M, Barve S, et al. Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky. Scientific Reports. 11: 18285. PMID 34521900 DOI: 10.1038/s41598-021-97423-z |
0.038 |
|
| Hide low-probability matches. |